Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer Patients
暂无分享,去创建一个
E. B. Butler | Zhibin Huang | N. Mayr | S. Lo | S. Blackmon | B. Teh | A. Blanco | A. Paulino | Daniel Y. Lee | M. Kim | Mirna Abboud | J. Santacruz | E. Butler
[1] L. Tanoue,et al. The National Comprehensive Cancer Network , 1998, Cancer.
[2] R. Barriger,et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.
[3] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[4] L. Kestin,et al. Stereotactic Radiotherapy Reduces Treatment Cost While Improving Overall Survival and Local Control Over Standard Fractionated Radiation Therapy for Medically Inoperable Non-Small-Cell Lung Cancer , 2011, American journal of clinical oncology.
[5] Feng Xu,et al. Clinical Analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma , 2011, Radiation oncology.
[6] Peter A S Johnstone,et al. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. , 2011, International journal of radiation oncology, biology, physics.
[7] Max Dahele,et al. Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[8] James Ze Wang,et al. Stereotactic body radiation therapy: a novel treatment modality , 2010, Nature Reviews Clinical Oncology.
[9] Edward Clouser,et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. , 2010, International journal of radiation oncology, biology, physics.
[10] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[11] Ke Sheng,et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[12] R. Whyte,et al. Stereotactic radiosurgery for lung tumors. , 2010, Seminars in thoracic and cardiovascular surgery.
[13] Samuel Ryu,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.
[14] Peter A S Johnstone,et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Lech Papiez,et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.
[16] A. Bezjak,et al. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] Jan Nyman,et al. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] Joe Y. Chang,et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[19] C. Yiannoutsos,et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[20] D. R. Jones. Natural History of Stage I Non-Small Cell Lung Cancer: Implications for Early Detection , 2008 .
[21] S. Ou,et al. Natural history of stage I non-small cell lung cancer: implications for early detection. , 2007, Chest.
[22] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Ping Li,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[24] W. Mühlnickel,et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases , 2006, Radiation oncology.
[25] J. Luketich,et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. , 2006, The Annals of thoracic surgery.
[26] J. Itami,et al. Clinical outcomes of single‐fraction stereotactic radiation therapy of lung tumors , 2006, Cancer.
[27] Jan Nyman,et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.
[28] K. Johansson,et al. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients. , 2006, Lung cancer.
[29] Masahiro Hiraoka,et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.
[30] Suresh Senan,et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. , 2005, International journal of radiation oncology, biology, physics.
[31] Branislav Jeremic,et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. , 2005, Lung cancer.
[32] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[33] Michael Flentje,et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. , 2004, International journal of radiation oncology, biology, physics.
[34] Stephanie Frost,et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. , 2003, Chest.
[35] John W Wong,et al. Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL. , 2003, International journal of radiation oncology, biology, physics.
[36] Shinichi Shimizu,et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. , 2003, International journal of radiation oncology, biology, physics.
[37] Koichi Yamazaki,et al. Real‐time tumor‐tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy , 2002, Cancer.
[38] J. Wong,et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.
[39] C. Williams,et al. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review , 2001, The Cochrane database of systematic reviews.
[40] C. Williams,et al. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review , 2001, Thorax.
[41] P. Corcoran,et al. Impact of revised stage classification of lung cancer on survival: a military experience. , 1999, Chest.
[42] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[43] R. Tsuchiya,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.
[44] C. Mountain,et al. A new international staging system for lung cancer. , 1987, Chest.